Xilio Therapeutics, Inc.

XLO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
ARS Apr 28, 2026 ARS
DEF 14A Apr 28, 2026 DEF 14A
4 Apr 16, 2026 4
3 Apr 16, 2026 3
8-K Apr 16, 2026 8-K
4 Mar 30, 2026 4
S-8 Mar 23, 2026 S-8
10-K Mar 23, 2026 10-K
8-K Mar 23, 2026 8-K
8-K Mar 12, 2026 8-K
8-K Mar 9, 2026 8-K
8-K Feb 24, 2026 8-K
4 Feb 17, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 13, 2026
8-K Feb 12, 2026 8-K
424B5 Feb 12, 2026 424B5
SCHEDULE 13G/A Feb 12, 2026
424B5 Feb 11, 2026 424B5
DEF 14A Jan 26, 2026 DEF 14A
PRE 14A Jan 16, 2026 PRE 14A
8-K Jan 8, 2026 8-K
4 Jan 5, 2026 4
4 Jan 5, 2026 4
← Newer Page 2 of 15 · 357 filings Older →